Phase 4 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Acquired Hemophilia A (AHA), a condition where the body mistakenly attacks a clotting protein in the blood
- Women who have gone through menopause, or women who could become pregnant but are using reliable contraception throughout the trial
- People who are able and willing to follow the trial's requirements and attend appointments as needed
Who may not be able to join:
- People born with hemophilia who have developed antibodies (inhibitors) that block treatment
- Women who are pregnant or breastfeeding
- People who test positive for hepatitis B, hepatitis C, HIV, or syphilis
- People who are unlikely to follow the trial's schedule or requirements
- People who are unable or unwilling to use contraception during the trial
- People with Acquired von Willebrand disease, a separate blood clotting condition
- People who, in the trial doctor's judgment, should not participate for any other medical reason
- People who received immune-suppressing treatment in the four weeks before joining, where the inhibitor levels were already steadily decreasing by less than half (confirm with trial site for exact details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lei Zhang, Chinese Academy of Medical Science and Blood Disease Hospital
Phone: +8613820261971
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Total response rate to treatment (OR) Total response rate to treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.